NEW YORK, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Investorideas.com, a leading investor news resource covering security and cannabis stocks, releases a snapshot looking
at the growing trend of U.S. listed cannabis-related companies listing in Canada and alternatively, some of Canada’s leading TSX
cannabis companies listing in the U.S. markets on the NYSE and NASDAQ. Companies mentioned: Aurora Cannabis Inc. (TSX: ACB.TO)
(NYSE: ACB),
DirectView Holdings, Inc. (OTC: DIRV), MedMen Enterprises, Inc. (CSE: MMEN.CN)
(OTC: MMNFF), Cronos Group Inc.
(NASDAQ:
CRON),( TSX:
CRON.TO).
Most recent news of a TSX company listing on the NYSE; Aurora Cannabis Inc. (TSX: ACB.TO)
(NYSE:
ACB) was approved for listing on the New York Stock Exchange and commenced trading effective October 23, 2018 under the symbol
ACB. Existing shares of Aurora, which previously traded on the OTCQX under the ticker symbol "ACBFF", will now trade on the
NYSE.
From the company news , "Our NYSE
listing represents another important milestone that reflects our commitment to all stakeholders as we continue advancing domestic
and international growth initiatives, which includes expanding our base of global institutional and retail investors," said Terry
Booth, CEO of Aurora. "Aurora has rapidly developed into a globally mature organization with industry leading and technologically
advanced production facilities available to produce at unprecedented scale to meet the growing demand for high-quality cannabis
both in Canada and abroad. We are also uniquely committed to leveraging our deep knowledge base to further scientific research into
medical applications of cannabis, and developing novel, higher-margin product offerings that strongly differentiate Aurora from our
competition.”
But the dual listing interest is coming from both directions. According to data and a source at the Canadian Securities
Exchange, TheCSE.com, there are 106 listed
companies in the cannabis sector, of which 49 are US related. In terms of dollars, US cannabis companies have raised $760
Million and the Canadians $780 Million through the end of September.
One small U.S. company, DirectView Holdings, Inc. (OTC: DIRV), that recently
entered the cannabis space with its security technology, is following the pack north and recently
announced that, “DirectView executives are exploring the possibility of bringing DirectView, Inc. to the TSX or CSE in
Canada, while still remaining on the OTC Markets in America.”
From the news, “In light of the recent legalization of Cannabis in Canada and the ever-growing demand for
surveillance and security equipment in the industry, DirectView is actively consulting with its legal team to dual list the
Company's stock on a Canadian stock exchange. The benefits of dual listing include a larger pool of investors, greater visibility,
and exposure to macroeconomic factors."
Talking about business opportunities in the cannabis sector, Roger Ralston, CEO and Chairman of DirectView Holdings, Inc.
(OTC: DIRV)
said in a recent interview on the NYSE, “In the
cannabis industry, security is required. For them to open their doors they have to have what we sell. Looking at all the industry
verticals his company sells into he also noted, “We have had a record first half in 2018, growing organically and through
acquisitions.”
One of the most recognized U.S. cannabis company listings on the CSE is MedMen Enterprises, Inc. (CSE: MMEN.CN)
(OTC: MMNFF), a Californian
cannabis retailer and one of the largest U.S. marijuana companies.
Looking at the significance of this milestone, an article in BloombergBNN notes, “Adam Bierman, CEO of MedMen, told BNN Bloomberg in
an interview Wednesday that Canada’s “forward-thinking mentality” makes it an attractive place for marijuana companies to go
public.”
Continued - “Canada has shown forward-thinking mentality on many issues and many industries and marijuana is
just the latest,” he said. “We found an amazing partner with the CSE. We believe that we’re kind of blazing a trail here, there’ll
be many to follow.”
Continued - “The California-based marijuana producer and retailer, known for its upscale Apple-like stores in
the U.S., said on Tuesday that it raised US$110 million based on an enterprise valuation of US$1.65 billion after completing a
reverse takeover of Ladera Ventures Corp. That makes it one of the most valuable U.S.-based cannabis companies to list in
Canada.”
Achieving a milestone of its own with the recognition of the NASDAQ’s first cannabis stock is Cronos Group Inc. (NASDAQ: CRON), (TSX: CRON.TO), a geographically
diversified and vertically integrated cannabis group.
Investor Ideas sat down in Vancouver at the ArcView Investor Forum and talked to Mike Gorenstein, CEO of Cronos (NASDAQ: CRON), (TSX: CRON.TO) and discussed how they
achieved their listing and its significance.
Mike told Investor Ideas, “I think the main thing was building our company in a compliant, institutional and respectable way and
approaching the NASDAQ and being able to present our business not as a “pot” company. We are a medicinal cannabis company; this is
what our business model is and they were receptive. It’s the way we approached it that worked.”
He also went on to say, “We hope that other companies do also go NASDAQ. A lot of people ask ‘what do you think happens?’
I think it’s an evolution and if you believe the cannabis industry will continue to evolve you will see other companies achieve a
listing.”
Hear the interview with Mike Gorenstein, CEO of Cronos Group Inc
https://www.investorideas.com/Audio/Podcasts/2018/051018-CRON.mp3
Other TSX companies have achieved US listings including Canopy Growth Corp. with its NYSE
listing on May 24, 2018, trading under the symbol CGC. The company said of its listing, “This listing follows a history of firsts for the Company including
being the first publicly traded, federally regulated cannabis company in North America, and the first to be included in the
S&P/TSX Composite index.”
Not to be left out, one of Canada’s other top cannabis companies, Aphria Inc., currently
trading on the TSX, has also recently applied to list its common shares on the New York Stock Exchange.
As paths are blazed north to south and south to north, it’s evident as Mike Gorenstein, CEO of Cronos, said, "the industry is
evolving."
For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC,
NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial
content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts, articles, podcasts and videos talking about cannabis, crypto,
technology including AI and Iota, mining, sports biotech, water, renewable energy and more. Investorideas.com original branded
content includes the daily Crypto
Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column and the Cleantech and Climate
Change Podcast.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation
and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring DIRV is a paid for
news release on Investorideas.com – third party , Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all
OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Contact Investorideas.com
800-665-0411
